vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and WEIBO Corp (WB). Click either name above to swap in a different company.
WEIBO Corp is the larger business by last-quarter revenue ($1.3B vs $749.2M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). WEIBO Corp runs the higher net margin — 35.7% vs 3.6%, a 32.1% gap on every dollar of revenue. Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 22.6%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.
CLOV vs WB — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $749.2M | $1.3B |
| Net Profit | $27.3M | $458.3M |
| Gross Margin | — | — |
| Operating Margin | 3.6% | 29.1% |
| Net Margin | 3.6% | 35.7% |
| Revenue YoY | 62.0% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $749.2M | — | ||
| Q4 25 | $487.7M | — | ||
| Q3 25 | $496.6M | $1.3B | ||
| Q2 25 | $477.6M | $841.7M | ||
| Q1 25 | $462.3M | $396.9M | ||
| Q4 24 | $337.0M | — | ||
| Q3 24 | $331.0M | $1.3B | ||
| Q2 24 | $356.3M | $833.4M |
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | — | ||
| Q3 25 | $-24.4M | $458.3M | ||
| Q2 25 | $-10.6M | $234.8M | ||
| Q1 25 | $-1.3M | $108.1M | ||
| Q4 24 | $-22.1M | — | ||
| Q3 24 | $-9.2M | $297.4M | ||
| Q2 24 | $7.4M | $164.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 30.3% | — |
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 29.1% | ||
| Q2 25 | -2.2% | 30.4% | ||
| Q1 25 | -0.3% | 27.8% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -2.7% | 29.0% | ||
| Q2 24 | 2.0% | 28.2% |
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 35.7% | ||
| Q2 25 | -2.2% | 27.9% | ||
| Q1 25 | -0.3% | 27.2% | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -2.8% | 22.9% | ||
| Q2 24 | 2.1% | 19.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.6M | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $339.4M | $3.9B |
| Total Assets | $697.7M | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | — | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $194.5M | — | ||
| Q3 24 | $288.0M | — | ||
| Q2 24 | $254.8M | $1.9B |
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | — | ||
| Q3 25 | $340.9M | $3.9B | ||
| Q2 25 | $344.2M | $3.6B | ||
| Q1 25 | $336.1M | $3.5B | ||
| Q4 24 | $341.1M | — | ||
| Q3 24 | $342.2M | — | ||
| Q2 24 | $324.9M | $3.4B |
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | — | ||
| Q3 25 | $559.7M | $6.9B | ||
| Q2 25 | $575.0M | $6.5B | ||
| Q1 25 | $583.7M | $6.7B | ||
| Q4 24 | $580.7M | — | ||
| Q3 24 | $653.0M | — | ||
| Q2 24 | $674.2M | $7.1B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
WB
| Income from operations | $373.2M | 29% |
| Shares used in computing diluted net income per share attributable to Weibos shareholders | $268.1M | 21% |
| Shares used in computing basic net income per share attributable to Weibos shareholders | $238.6M | 19% |
| Value-added services | $186.1M | 14% |
| Less: Income tax expenses | $113.2M | 9% |
| Investment related income, net | $45.0M | 4% |
| Product development | $16.7M | 1% |
| General and administrative | $10.6M | 1% |
| Sales and marketing | $7.1M | 1% |
| Accretion to redeemable non-controlling interests | $3.0M | 0% |
